Yunfeng Ni

Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)

Xiaolong Yan, Hongtao Duan, Yunfeng Ni et al. · International Journal of Surgery · 2022 · 234 citations

Medicine, Oncology, Surgery +13

Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice

Yunfeng Ni, Jian Wang, Xiaolong Yan et al. · Respiratory Research · 2010 · 130 citations · Full text

Medicine, Immunology, Pharmacology +16

Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung Cancer

Jie Lei, Jinbo Zhao, Li Gong et al. · JAMA Oncology · 2023 · 98 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Glycyrrhizin Treatment Is Associated with Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Expression

Yunfeng Ni, Jianke Kuai, Zifan Lu et al. · Journal of Surgical Research · 2010 · 93 citations

Medicine, Immunology, Pharmacology +13

Lung cancer A549 cells migrate directionally in DC electric fields with polarized and activated EGFRs

Xiaolong Yan, Jing Han, Zhipei Zhang et al. · Bioelectromagnetics · 2008 · 75 citations

Life Sciences, Cell Biology, Oncology +15